These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 23459460

  • 1. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
    Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N.
    PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
    [Abstract] [Full Text] [Related]

  • 2. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
    Savary G, Dewaeles E, Diazzi S, Buscot M, Nottet N, Fassy J, Courcot E, Henaoui IS, Lemaire J, Martis N, Van der Hauwaert C, Pons N, Magnone V, Leroy S, Hofman V, Plantier L, Lebrigand K, Paquet A, Lino Cardenas CL, Vassaux G, Hofman P, Günther A, Crestani B, Wallaert B, Rezzonico R, Brousseau T, Glowacki F, Bellusci S, Perrais M, Broly F, Barbry P, Marquette CH, Cauffiez C, Mari B, Pottier N.
    Am J Respir Crit Care Med; 2019 Jul 15; 200(2):184-198. PubMed ID: 30964696
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E.
    J Exp Med; 2010 Aug 02; 207(8):1589-97. PubMed ID: 20643828
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.
    Shi L, Han Q, Hong Y, Li W, Gong G, Cui J, Mao M, Liang X, Hu B, Li X, Luo Q, Zhang Y.
    Stem Cell Res Ther; 2021 Feb 25; 12(1):147. PubMed ID: 33632305
    [Abstract] [Full Text] [Related]

  • 6. Lung fibroblasts express a miR-19a-19b-20a sub-cluster to suppress TGF-β-associated fibroblast activation in murine pulmonary fibrosis.
    Souma K, Shichino S, Hashimoto S, Ueha S, Tsukui T, Nakajima T, Suzuki HI, Shand FHW, Inagaki Y, Nagase T, Matsushima K.
    Sci Rep; 2018 Nov 09; 8(1):16642. PubMed ID: 30413725
    [Abstract] [Full Text] [Related]

  • 7. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y, Zhao X, Sun J, Su W, Zhang L, Li Y, Liu Y, Zhang L, Lu Y, Shan H, Liang H.
    Cell Death Differ; 2019 Sep 09; 26(9):1832-1844. PubMed ID: 30644438
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
    Chen Y, Zhang Q, Zhou Y, Yang Z, Tan M.
    Hum Exp Toxicol; 2020 May 09; 39(5):683-695. PubMed ID: 31884830
    [Abstract] [Full Text] [Related]

  • 9. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
    Deng W, Zhang Y, Fang P, Shi H, Yang S.
    Environ Toxicol; 2022 Oct 09; 37(10):2375-2387. PubMed ID: 35785413
    [Abstract] [Full Text] [Related]

  • 10. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
    Pattnaik B, Negi V, Chaudhuri R, Desiraju K, Faizan MI, Akhtar A, Ansari MS, Shakir M, Gheware A, Prakash YS, Guleria R, Ghosh B, Agrawal A, Ahmad T.
    Cell Mol Life Sci; 2023 Nov 11; 80(12):357. PubMed ID: 37950757
    [Abstract] [Full Text] [Related]

  • 11. MiR-340-5p mitigates the proliferation and activation of fibroblast in lung fibrosis by targeting TGF-β/p38/ATF1 signaling pathway.
    Wei YQ, Guo YF, Yang SM, Ma HH, Li J.
    Eur Rev Med Pharmacol Sci; 2020 Jun 11; 24(11):6252-6261. PubMed ID: 32572892
    [Abstract] [Full Text] [Related]

  • 12. The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis.
    Ji X, Wu B, Fan J, Han R, Luo C, Wang T, Yang J, Han L, Zhu B, Wei D, Chen J, Ni C.
    Sci Rep; 2015 Sep 15; 5():14131. PubMed ID: 26370615
    [Abstract] [Full Text] [Related]

  • 13. C-MYC induces idiopathic pulmonary fibrosis via modulation of miR-9-5p-mediated TBPL1.
    Qin H, Tang Y, Mao Y, Zhou X, Xu T, Liu W, Su X.
    Cell Signal; 2022 May 15; 93():110274. PubMed ID: 35122989
    [Abstract] [Full Text] [Related]

  • 14. CDKN2B antisense RNA 1 expression alleviates idiopathic pulmonary fibrosis by functioning as a competing endogenouse RNA through the miR-199a-5p/Sestrin-2 axis.
    Yang M, Yin E, Xu Y, Liu Y, Li T, Dong Z, Tai W.
    Bioengineered; 2022 Mar 15; 13(3):7746-7759. PubMed ID: 35291918
    [Abstract] [Full Text] [Related]

  • 15. MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A.
    Ren L, Yang C, Dou Y, Zhan R, Sun Y, Yu Y.
    Exp Lung Res; 2017 Mar 15; 43(6-7):249-258. PubMed ID: 28816543
    [Abstract] [Full Text] [Related]

  • 16. LncRNA Hoxaas3 promotes lung fibroblast activation and fibrosis by targeting miR-450b-5p to regulate Runx1.
    Lin S, Zhang R, Xu L, Ma R, Xu L, Zhu L, Hu J, An X.
    Cell Death Dis; 2020 Aug 26; 11(8):706. PubMed ID: 32848140
    [Abstract] [Full Text] [Related]

  • 17. Plant miRNA osa-miR172d-5p suppressed lung fibrosis by targeting Tab1.
    Kumazoe M, Ogawa F, Hikida A, Shimada Y, Yoshitomi R, Watanabe R, Onda H, Fujimura Y, Tachibana H.
    Sci Rep; 2023 Feb 06; 13(1):2128. PubMed ID: 36746980
    [Abstract] [Full Text] [Related]

  • 18. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H, Liu S, Chen Y, Bai X, Liu L, Dong Y, Hu M, Su X, Chen Y, Huangfu L, Li X, Gu Y, Shan H.
    J Mol Med (Berl); 2016 Jun 06; 94(6):655-65. PubMed ID: 26787543
    [Abstract] [Full Text] [Related]

  • 19. Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis.
    Guiot J, Henket M, Remacle C, Cambier M, Struman I, Winandy M, Moermans C, Louis E, Malaise M, Ribbens C, Louis R, Njock MS.
    Respir Res; 2023 Apr 15; 24(1):112. PubMed ID: 37061683
    [Abstract] [Full Text] [Related]

  • 20. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
    Vittal R, Walker NM, McLinden AP, Braeuer RR, Ke F, Fattahi F, Combs MP, Misumi K, Aoki Y, Wheeler DS, Wilke CA, Huang SK, Moore BB, Cao P, Lama VN.
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan 01; 326(1):L39-L51. PubMed ID: 37933452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.